In older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone: Commentary

Amy T. Wang, Steven A. Smith

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'In older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone: Commentary'. Together they form a unique fingerprint.